Yoshida N, Sugimoto N, Hirayama F, Nakamura Y, Ichikawa H, Naito Y, Yoshikawa T
First Department of Internal Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Gut. 2002 May;50(5):594-8. doi: 10.1136/gut.50.5.594.
Helicobacter pylori infection and non-steroidal anti-inflammatory drugs are two major causes of gastric ulceration but interactions between H pylori and these drugs in gastric mucosal injury are unclear.
We studied the influence of experimental H pylori infection on gastric mucosal injury induced by aspirin.
Male Mongolian gerbils free of specific pathogens were used.
H pylori ATCC43504 culture broth was administered by oral gavage at seven weeks of age. After three weeks, acidified aspirin (400 mg/kg) was administered orally, and three hours later the total area of gastric erosions, myeloperoxidase (MPO) activity (an index of neutrophil accumulation), thiobarbituric acid reactive substances (TBARS, an index of lipid peroxidation), and KC/GRO (a chemoattractive cytokine in rodents) were measured in gastric mucosa. To determine the role of neutrophils in these circumstances, antigerbil neutrophil rabbit serum (ANS) was administered to some animals 18 hours before aspirin.
Aspirin caused more extensive haemorrhagic erosions (33.1 (12.3) mm2) associated with greater MPO activity (1887.7 (598.5) microU/mg protein) and TBARS (0.33 (0.14) nmol/mg protein) and KC/GRO concentrations (28.3 (9.5) pg/mg protein) in infected than in uninfected gerbils (13.7 (2.3); 204.0 (68.9); 0.12 (0.06); 3.1 (0.8), respectively) Pretreatment with ANS inhibited the increases in gastric erosions, MPO activity, and TBARS but not KC/GRO concentration. The reduction in aspirin induced mucosal injury by administration of ANS was much greater in H pylori infected animals (65%) than in uninfected animals (31%).
H pylori infection potentiates aspirin induced gastric mucosal injury by mechanisms that include accumulation of activated neutrophils.
幽门螺杆菌感染和非甾体类抗炎药是胃溃疡的两个主要病因,但幽门螺杆菌与这些药物在胃黏膜损伤中的相互作用尚不清楚。
我们研究了实验性幽门螺杆菌感染对阿司匹林所致胃黏膜损伤的影响。
使用无特定病原体的雄性蒙古沙鼠。
7周龄时经口灌胃给予幽门螺杆菌ATCC43504培养液。3周后,口服酸化阿司匹林(400mg/kg),3小时后测量胃黏膜糜烂总面积、髓过氧化物酶(MPO)活性(中性粒细胞聚集指标)、硫代巴比妥酸反应物质(TBARS,脂质过氧化指标)以及KC/GRO(啮齿动物中的一种趋化细胞因子)。为确定中性粒细胞在这些情况下的作用,在给予阿司匹林前18小时给部分动物注射抗沙鼠中性粒细胞兔血清(ANS)。
与未感染的沙鼠相比,感染的沙鼠服用阿司匹林后出现更广泛的出血性糜烂(33.1(12.3)mm²),伴有更高的MPO活性(1887.7(598.5)微单位/毫克蛋白)、TBARS(0.33(0.14)纳摩尔/毫克蛋白)和KC/GRO浓度(28.3(9.5)皮克/毫克蛋白)(未感染沙鼠分别为13.7(2.3);204.0(68.9);0.12(0.06);3.1(0.8))。ANS预处理可抑制胃糜烂、MPO活性和TBARS的增加,但不能抑制KC/GRO浓度。给予ANS减轻阿司匹林诱导的黏膜损伤在幽门螺杆菌感染的动物中(65%)比未感染的动物中(31%)更显著。
幽门螺杆菌感染通过包括活化中性粒细胞聚集在内的机制增强阿司匹林诱导的胃黏膜损伤。